Comparative study of two antimicrobial dressings in infected leg ulcers: a pilot study
-
- G. Mosti
- Head Angiology Department, All at Angiology Department, Barbantini Hospital, Lucca, Italy Via del Calcio 2, 55100 Lucca, Italy
-
- A. Magliaro
- Consultant Dermatologist, All at Angiology Department, Barbantini Hospital, Lucca, Italy Via del Calcio 2, 55100 Lucca, Italy
-
- V. Mattaliano
- Consultant Vascular Surgeon, All at Angiology Department, Barbantini Hospital, Lucca, Italy Via del Calcio 2, 55100 Lucca, Italy
-
- P. Picerni
- Senior Registrar, All at Angiology Department, Barbantini Hospital, Lucca, Italy Via del Calcio 2, 55100 Lucca, Italy
-
- N. Angelotti
- Consultant Dermatologist, All at Angiology Department, Barbantini Hospital, Lucca, Italy Via del Calcio 2, 55100 Lucca, Italy
書誌事項
- 公開日
- 2015-03-02
- DOI
-
- 10.12968/jowc.2015.24.3.121
- 公開者
- Mark Allen Group
この論文をさがす
説明
<jats:sec><jats:title>Objective:</jats:title><jats:p> The aim of the study was to compare the efficacy of a microorganism-binding (MB) dressing with a silver-containing hydrofiber (SCH) dressing in controlling the bacterial loads of heavily colonised or locally infected chronic venous leg ulcers, before surgical management with homologous skin grafts. </jats:p></jats:sec><jats:sec><jats:title>Method:</jats:title><jats:p> A randomised comparative single centre study recruited patients presenting with hard-to-heal critically colonised or locally infected leg ulcers, who could be treated with skin grafting. Inclusion criteria included; ulcers of vascular aetiology, over 18 years old, a wound duration ≥6 months and ankle brachial index (ABPI) >0.6. Patients were randomly assigned to treatment with SCH dressings (Aquacel Ag) or MB dressing (Cutimed Sorbact). Dressings were changed daily over a four-day observation period, after which they were taken for a skin grafting procedure. Swab samples from ulcer beds were taken in order to quantify the bacterial load at inclusion (D0) and at the end of the observation period day 4 (D4). No antibiotics were administered before or during the evaluation period. </jats:p></jats:sec><jats:sec><jats:title>Results:</jats:title><jats:p> Both groups (n=20 SCH, n=20 MB) were similar in gender, age, pathophysiology (both had 15 patients with venous leg ulcers and 5 with arterial leg ulcers), ulcer surface, ulcer duration, treatment-related pain and initial bacterial load. Analysing bacterial load variation showed a significant reduction of bacterial burden at D4 in both groups. In the SCH group, we found an average bacterial load reduction of 41.6%, with an average reduction of 73.1% in the MB group (p< 0.00001). No serious adverse events were reported. </jats:p></jats:sec><jats:sec><jats:title>Conclusion:</jats:title><jats:p> Our evaluation confirmed that MB and SCH dressings are effective in reducing the bacterial burden in critically colonised or locally infected chronic leg ulcers, without inducing adverse events, with MB dressings significantly more effective. </jats:p></jats:sec><jats:sec><jats:title>Declaration of interest:</jats:title><jats:p> There were no external sources of funding for this study. The authors have no conflicts of interest to declare. </jats:p></jats:sec>
収録刊行物
-
- Journal of Wound Care
-
Journal of Wound Care 24 (3), 121-127, 2015-03-02
Mark Allen Group